Literature DB >> 33947204

Phenylephrine Provocation to Evaluate the Cause of Mitral Regurgitation in Patients With Obstructive Hypertrophic Cardiomyopathy.

Jonathan D Moreno1, Richard G Bach1, Ralph J Damiano2, Sara C Martinez1, Sharon Cresci1,3.   

Abstract

Entities:  

Keywords:  blood pressure; cardiomyopathies; echocardiography; mitral valve; phenylephrine

Mesh：

Substances：

Year:  2021        PMID： 33947204      PMCID： PMC8394282          DOI： 10.1161/CIRCIMAGING.121.012656

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN： 1941-9651            Impact factor:   7.792


× No keyword cloud information.
  5 in total

Review 1.  Transaortic septal myectomy: techniques and pitfalls.

Authors:  Anthony Ralph-Edwards; Rachel D Vanderlaan; Pietro Bajona
Journal:  Ann Cardiothorac Surg       Date:  2017-07

2.  Outcome and undertreatment of mitral regurgitation: a community cohort study.

Authors:  Volha Dziadzko; Marie-Annick Clavel; Mikhail Dziadzko; Jose R Medina-Inojosa; Hector Michelena; Joseph Maalouf; Vuyisile Nkomo; Prabin Thapa; Maurice Enriquez-Sarano
Journal:  Lancet       Date:  2018-03-10       Impact factor: 79.321

3.  Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction.

Authors:  Martin S Maron; Iacopo Olivotto; Andrey G Zenovich; Mark S Link; Natesa G Pandian; Jeffery T Kuvin; Stefano Nistri; Franco Cecchi; James E Udelson; Barry J Maron
Journal:  Circulation       Date:  2006-11-06       Impact factor: 29.690

4.  Transesophageal Doppler echocardiography in obstructive hypertrophic cardiomyopathy: clarification of pathophysiology and importance in intraoperative decision making.

Authors:  L E Grigg; E D Wigle; W G Williams; L B Daniel; H Rakowski
Journal:  J Am Coll Cardiol       Date:  1992-07       Impact factor: 24.094

5.  Can the echocardiographic LV mass equation reliably demonstrate stable LV mass following acute change in LV load?

Authors:  Kavisha Patel; Nidhish Tiwari; Wilbert S Aronow; Daniel Spevack
Journal:  Ann Transl Med       Date:  2019-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.